KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹307 Cr | ₹251 Cr | ₹456 Cr | ₹262 Cr | ₹139 Cr |
What is the latest Revenue of KWALITY PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹307 Cr |
| Mar2024 | ₹251 Cr |
| Mar2023 | ₹456 Cr |
| Mar2022 | ₹262 Cr |
| Mar2021 | ₹139 Cr |
How is Revenue of KWALITY PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹307 Cr | 22.36 | |
| Mar2024 | ₹251 Cr | -44.97 | |
| Mar2023 | ₹456 Cr | 74.11 | |
| Mar2022 | ₹262 Cr | 88.10 | |
| Mar2021 | ₹139 Cr | - | |
Compare Revenue of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹2,656.4 Cr | -6.2% | 12.5% | 120.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | -6.2% |
12.5% |
120.1% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses